- Home
- ROIV vs SAIA Comparison
ROIV vs SAIA Comparison
Compare ROIV & SAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SAIA
- Stock Information
- Founded
- ROIV 2014
- SAIA 1924
- Country
- ROIV United Kingdom
- SAIA United States
- Employees
- ROIV N/A
- SAIA N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SAIA Trucking Freight/Courier Services
- Sector
- ROIV Health Care
- SAIA Industrials
- Exchange
- ROIV Nasdaq
- SAIA Nasdaq
- Market Cap
- ROIV 7.8B
- SAIA 7.6B
- IPO Year
- ROIV N/A
- SAIA 2002
- Fundamental
- Price
- ROIV $11.55
- SAIA $333.61
- Analyst Decision
- ROIV Buy
- SAIA Buy
- Analyst Count
- ROIV 3
- SAIA 18
- Target Price
- ROIV $15.25
- SAIA $366.28
- AVG Volume (30 Days)
- ROIV 6.5M
- SAIA 624.4K
- Earning Date
- ROIV 08-07-2025
- SAIA 07-25-2025
- Dividend Yield
- ROIV N/A
- SAIA N/A
- EPS Growth
- ROIV N/A
- SAIA N/A
- EPS
- ROIV N/A
- SAIA 11.99
- Revenue
- ROIV $29,053,000.00
- SAIA $3,241,874,000.00
- Revenue This Year
- ROIV $3.28
- SAIA $2.52
- Revenue Next Year
- ROIV $156.84
- SAIA $7.17
- P/E Ratio
- ROIV N/A
- SAIA $26.00
- Revenue Growth
- ROIV N/A
- SAIA 8.95
- 52 Week Low
- ROIV $8.73
- SAIA $229.12
- 52 Week High
- ROIV $13.06
- SAIA $624.55
- Technical
- Relative Strength Index (RSI)
- ROIV 55.27
- SAIA 72.58
- Support Level
- ROIV $11.31
- SAIA $302.29
- Resistance Level
- ROIV $11.64
- SAIA $313.54
- Average True Range (ATR)
- ROIV 0.29
- SAIA 12.86
- MACD
- ROIV 0.00
- SAIA 3.02
- Stochastic Oscillator
- ROIV 78.60
- SAIA 70.28
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.